NT3成長因子受容体の世界市場（～2026年）

• 英文タイトル：Global NT 3 Growth Factor Receptor Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY08247 • 出版社/出版日：QYResearch / 2020年11月20日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はNT3成長因子受容体のグローバル市場について調査・分析したレポートです。種類別（AZD-7451、ラロトレクチニブ、DS-6051、LM-22B10、その他）市場規模、用途別（乳がん、脳がん、固形腫瘍、大腸がん、線維肉腫、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別NT3成長因子受容体の競争状況、市場シェア ・世界のNT3成長因子受容体市場：種類別市場規模 2015年-2020年（AZD-7451、ラロトレクチニブ、DS-6051、LM-22B10、その他） ・世界のNT3成長因子受容体市場：種類別市場規模予測 2021年-2026年（AZD-7451、ラロトレクチニブ、DS-6051、LM-22B10、その他） ・世界のNT3成長因子受容体市場：用途別市場規模 2015年-2020年（乳がん、脳がん、固形腫瘍、大腸がん、線維肉腫、その他） ・世界のNT3成長因子受容体市場：用途別市場規模予測 2021年-2026年（乳がん、脳がん、固形腫瘍、大腸がん、線維肉腫、その他） ・北米のNT3成長因子受容体市場分析：米国、カナダ ・ヨーロッパのNT3成長因子受容体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのNT3成長因子受容体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のNT3成長因子受容体市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのNT3成長因子受容体市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Array BioPharma Inc、AstraZeneca Plc、Daiichi Sankyo Company Ltd、Handok Inc、Ignyta Inc、Loxo Oncology Inc、Netris Pharma SAS、Plexxikon Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global NT 3 Growth Factor Receptor Market
The global NT 3 Growth Factor Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global NT 3 Growth Factor Receptor Scope and Market Size
NT 3 Growth Factor Receptor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NT 3 Growth Factor Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the NT 3 Growth Factor Receptor market is segmented into
AZD-7451
Larotrectinib
DS-6051
LM-22B10
Others

Segment by Application, the NT 3 Growth Factor Receptor market is segmented into
Breast Cancer
Brain Cancer
Solid Tumor
Colon Cancer
Fibrosarcoma
Others

Regional and Country-level Analysis
The NT 3 Growth Factor Receptor market is analysed and market size information is provided by regions (countries).
The key regions covered in the NT 3 Growth Factor Receptor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and NT 3 Growth Factor Receptor Market Share Analysis
NT 3 Growth Factor Receptor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in NT 3 Growth Factor Receptor business, the date to enter into the NT 3 Growth Factor Receptor market, NT 3 Growth Factor Receptor product introduction, recent developments, etc.

The major vendors covered:
Array BioPharma Inc
AstraZeneca Plc
Daiichi Sankyo Company Ltd
Handok Inc
Ignyta Inc
Loxo Oncology Inc
Netris Pharma SAS
Plexxikon Inc

レポート目次

---

1 Study Coverage
1.1 NT 3 Growth Factor Receptor Product Introduction
1.2 Market Segments
1.3 Key NT 3 Growth Factor Receptor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global NT 3 Growth Factor Receptor Market Size Growth Rate by Type
1.4.2 AZD-7451
1.4.3 Larotrectinib
1.4.4 DS-6051
1.4.5 LM-22B10
1.4.6 Others
1.5 Market by Application
1.5.1 Global NT 3 Growth Factor Receptor Market Size Growth Rate by Application
1.5.2 Breast Cancer
1.5.3 Brain Cancer
1.5.4 Solid Tumor
1.5.5 Colon Cancer
1.5.6 Fibrosarcoma
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global NT 3 Growth Factor Receptor Market Size, Estimates and Forecasts
2.1.1 Global NT 3 Growth Factor Receptor Revenue 2015-2026
2.1.2 Global NT 3 Growth Factor Receptor Sales 2015-2026
2.2 Global NT 3 Growth Factor Receptor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global NT 3 Growth Factor Receptor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global NT 3 Growth Factor Receptor Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global NT 3 Growth Factor Receptor Competitor Landscape by Players
3.1 NT 3 Growth Factor Receptor Sales by Manufacturers
3.1.1 NT 3 Growth Factor Receptor Sales by Manufacturers (2015-2020)
3.1.2 NT 3 Growth Factor Receptor Sales Market Share by Manufacturers (2015-2020)
3.2 NT 3 Growth Factor Receptor Revenue by Manufacturers
3.2.1 NT 3 Growth Factor Receptor Revenue by Manufacturers (2015-2020)
3.2.2 NT 3 Growth Factor Receptor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global NT 3 Growth Factor Receptor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by NT 3 Growth Factor Receptor Revenue in 2019
3.2.5 Global NT 3 Growth Factor Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 NT 3 Growth Factor Receptor Price by Manufacturers
3.4 NT 3 Growth Factor Receptor Manufacturing Base Distribution, Product Types
3.4.1 NT 3 Growth Factor Receptor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers NT 3 Growth Factor Receptor Product Type
3.4.3 Date of International Manufacturers Enter into NT 3 Growth Factor Receptor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global NT 3 Growth Factor Receptor Market Size by Type (2015-2020)
4.1.1 Global NT 3 Growth Factor Receptor Sales by Type (2015-2020)
4.1.2 Global NT 3 Growth Factor Receptor Revenue by Type (2015-2020)
4.1.3 NT 3 Growth Factor Receptor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global NT 3 Growth Factor Receptor Market Size Forecast by Type (2021-2026)
4.2.1 Global NT 3 Growth Factor Receptor Sales Forecast by Type (2021-2026)
4.2.2 Global NT 3 Growth Factor Receptor Revenue Forecast by Type (2021-2026)
4.2.3 NT 3 Growth Factor Receptor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global NT 3 Growth Factor Receptor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global NT 3 Growth Factor Receptor Market Size by Application (2015-2020)
5.1.1 Global NT 3 Growth Factor Receptor Sales by Application (2015-2020)
5.1.2 Global NT 3 Growth Factor Receptor Revenue by Application (2015-2020)
5.1.3 NT 3 Growth Factor Receptor Price by Application (2015-2020)
5.2 NT 3 Growth Factor Receptor Market Size Forecast by Application (2021-2026)
5.2.1 Global NT 3 Growth Factor Receptor Sales Forecast by Application (2021-2026)
5.2.2 Global NT 3 Growth Factor Receptor Revenue Forecast by Application (2021-2026)
5.2.3 Global NT 3 Growth Factor Receptor Price Forecast by Application (2021-2026)

6 North America
6.1 North America NT 3 Growth Factor Receptor by Country
6.1.1 North America NT 3 Growth Factor Receptor Sales by Country
6.1.2 North America NT 3 Growth Factor Receptor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America NT 3 Growth Factor Receptor Market Facts & Figures by Type
6.3 North America NT 3 Growth Factor Receptor Market Facts & Figures by Application

7 Europe
7.1 Europe NT 3 Growth Factor Receptor by Country
7.1.1 Europe NT 3 Growth Factor Receptor Sales by Country
7.1.2 Europe NT 3 Growth Factor Receptor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe NT 3 Growth Factor Receptor Market Facts & Figures by Type
7.3 Europe NT 3 Growth Factor Receptor Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific NT 3 Growth Factor Receptor by Region
8.1.1 Asia Pacific NT 3 Growth Factor Receptor Sales by Region
8.1.2 Asia Pacific NT 3 Growth Factor Receptor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific NT 3 Growth Factor Receptor Market Facts & Figures by Type
8.3 Asia Pacific NT 3 Growth Factor Receptor Market Facts & Figures by Application

9 Latin America
9.1 Latin America NT 3 Growth Factor Receptor by Country
9.1.1 Latin America NT 3 Growth Factor Receptor Sales by Country
9.1.2 Latin America NT 3 Growth Factor Receptor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America NT 3 Growth Factor Receptor Market Facts & Figures by Type
9.3 Central & South America NT 3 Growth Factor Receptor Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa NT 3 Growth Factor Receptor by Country
10.1.1 Middle East and Africa NT 3 Growth Factor Receptor Sales by Country
10.1.2 Middle East and Africa NT 3 Growth Factor Receptor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa NT 3 Growth Factor Receptor Market Facts & Figures by Type
10.3 Middle East and Africa NT 3 Growth Factor Receptor Market Facts & Figures by Application

11 Company Profiles
11.1 Array BioPharma Inc
11.1.1 Array BioPharma Inc Corporation Information
11.1.2 Array BioPharma Inc Description and Business Overview
11.1.3 Array BioPharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Array BioPharma Inc NT 3 Growth Factor Receptor Products Offered
11.1.5 Array BioPharma Inc Related Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Corporation Information
11.2.2 AstraZeneca Plc Description and Business Overview
11.2.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Plc NT 3 Growth Factor Receptor Products Offered
11.2.5 AstraZeneca Plc Related Developments
11.3 Daiichi Sankyo Company Ltd
11.3.1 Daiichi Sankyo Company Ltd Corporation Information
11.3.2 Daiichi Sankyo Company Ltd Description and Business Overview
11.3.3 Daiichi Sankyo Company Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Products Offered
11.3.5 Daiichi Sankyo Company Ltd Related Developments
11.4 Handok Inc
11.4.1 Handok Inc Corporation Information
11.4.2 Handok Inc Description and Business Overview
11.4.3 Handok Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Handok Inc NT 3 Growth Factor Receptor Products Offered
11.4.5 Handok Inc Related Developments
11.5 Ignyta Inc
11.5.1 Ignyta Inc Corporation Information
11.5.2 Ignyta Inc Description and Business Overview
11.5.3 Ignyta Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Ignyta Inc NT 3 Growth Factor Receptor Products Offered
11.5.5 Ignyta Inc Related Developments
11.6 Loxo Oncology Inc
11.6.1 Loxo Oncology Inc Corporation Information
11.6.2 Loxo Oncology Inc Description and Business Overview
11.6.3 Loxo Oncology Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Loxo Oncology Inc NT 3 Growth Factor Receptor Products Offered
11.6.5 Loxo Oncology Inc Related Developments
11.7 Netris Pharma SAS
11.7.1 Netris Pharma SAS Corporation Information
11.7.2 Netris Pharma SAS Description and Business Overview
11.7.3 Netris Pharma SAS Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Netris Pharma SAS NT 3 Growth Factor Receptor Products Offered
11.7.5 Netris Pharma SAS Related Developments
11.8 Plexxikon Inc
11.8.1 Plexxikon Inc Corporation Information
11.8.2 Plexxikon Inc Description and Business Overview
11.8.3 Plexxikon Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Plexxikon Inc NT 3 Growth Factor Receptor Products Offered
11.8.5 Plexxikon Inc Related Developments
11.1 Array BioPharma Inc
11.1.1 Array BioPharma Inc Corporation Information
11.1.2 Array BioPharma Inc Description and Business Overview
11.1.3 Array BioPharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Array BioPharma Inc NT 3 Growth Factor Receptor Products Offered
11.1.5 Array BioPharma Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 NT 3 Growth Factor Receptor Market Estimates and Projections by Region
12.1.1 Global NT 3 Growth Factor Receptor Sales Forecast by Regions 2021-2026
12.1.2 Global NT 3 Growth Factor Receptor Revenue Forecast by Regions 2021-2026
12.2 North America NT 3 Growth Factor Receptor Market Size Forecast (2021-2026)
12.2.1 North America: NT 3 Growth Factor Receptor Sales Forecast (2021-2026)
12.2.2 North America: NT 3 Growth Factor Receptor Revenue Forecast (2021-2026)
12.2.3 North America: NT 3 Growth Factor Receptor Market Size Forecast by Country (2021-2026)
12.3 Europe NT 3 Growth Factor Receptor Market Size Forecast (2021-2026)
12.3.1 Europe: NT 3 Growth Factor Receptor Sales Forecast (2021-2026)
12.3.2 Europe: NT 3 Growth Factor Receptor Revenue Forecast (2021-2026)
12.3.3 Europe: NT 3 Growth Factor Receptor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific NT 3 Growth Factor Receptor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: NT 3 Growth Factor Receptor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: NT 3 Growth Factor Receptor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: NT 3 Growth Factor Receptor Market Size Forecast by Region (2021-2026)
12.5 Latin America NT 3 Growth Factor Receptor Market Size Forecast (2021-2026)
12.5.1 Latin America: NT 3 Growth Factor Receptor Sales Forecast (2021-2026)
12.5.2 Latin America: NT 3 Growth Factor Receptor Revenue Forecast (2021-2026)
12.5.3 Latin America: NT 3 Growth Factor Receptor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa NT 3 Growth Factor Receptor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: NT 3 Growth Factor Receptor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: NT 3 Growth Factor Receptor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: NT 3 Growth Factor Receptor Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key NT 3 Growth Factor Receptor Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 NT 3 Growth Factor Receptor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. NT 3 Growth Factor Receptor Market Segments
Table 2. Ranking of Global Top NT 3 Growth Factor Receptor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global NT 3 Growth Factor Receptor Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AZD-7451
Table 5. Major Manufacturers of Larotrectinib
Table 6. Major Manufacturers of DS-6051
Table 7. Major Manufacturers of LM-22B10
Table 8. Major Manufacturers of Others
Table 9. Global NT 3 Growth Factor Receptor Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global NT 3 Growth Factor Receptor Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global NT 3 Growth Factor Receptor Sales by Regions 2015-2020 (K Pcs)
Table 12. Global NT 3 Growth Factor Receptor Sales Market Share by Regions (2015-2020)
Table 13. Global NT 3 Growth Factor Receptor Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global NT 3 Growth Factor Receptor Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global NT 3 Growth Factor Receptor Sales Share by Manufacturers (2015-2020)
Table 16. Global NT 3 Growth Factor Receptor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global NT 3 Growth Factor Receptor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NT 3 Growth Factor Receptor as of 2019)
Table 18. NT 3 Growth Factor Receptor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. NT 3 Growth Factor Receptor Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers NT 3 Growth Factor Receptor Price (2015-2020) (USD/Pcs)
Table 21. NT 3 Growth Factor Receptor Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers NT 3 Growth Factor Receptor Product Type
Table 23. Date of International Manufacturers Enter into NT 3 Growth Factor Receptor Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global NT 3 Growth Factor Receptor Sales by Type (2015-2020) (K Pcs)
Table 26. Global NT 3 Growth Factor Receptor Sales Share by Type (2015-2020)
Table 27. Global NT 3 Growth Factor Receptor Revenue by Type (2015-2020) (US$ Million)
Table 28. Global NT 3 Growth Factor Receptor Revenue Share by Type (2015-2020)
Table 29. NT 3 Growth Factor Receptor Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global NT 3 Growth Factor Receptor Sales by Application (2015-2020) (K Pcs)
Table 31. Global NT 3 Growth Factor Receptor Sales Share by Application (2015-2020)
Table 32. North America NT 3 Growth Factor Receptor Sales by Country (2015-2020) (K Pcs)
Table 33. North America NT 3 Growth Factor Receptor Sales Market Share by Country (2015-2020)
Table 34. North America NT 3 Growth Factor Receptor Revenue by Country (2015-2020) (US$ Million)
Table 35. North America NT 3 Growth Factor Receptor Revenue Market Share by Country (2015-2020)
Table 36. North America NT 3 Growth Factor Receptor Sales by Type (2015-2020) (K Pcs)
Table 37. North America NT 3 Growth Factor Receptor Sales Market Share by Type (2015-2020)
Table 38. North America NT 3 Growth Factor Receptor Sales by Application (2015-2020) (K Pcs)
Table 39. North America NT 3 Growth Factor Receptor Sales Market Share by Application (2015-2020)
Table 40. Europe NT 3 Growth Factor Receptor Sales by Country (2015-2020) (K Pcs)
Table 41. Europe NT 3 Growth Factor Receptor Sales Market Share by Country (2015-2020)
Table 42. Europe NT 3 Growth Factor Receptor Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe NT 3 Growth Factor Receptor Revenue Market Share by Country (2015-2020)
Table 44. Europe NT 3 Growth Factor Receptor Sales by Type (2015-2020) (K Pcs)
Table 45. Europe NT 3 Growth Factor Receptor Sales Market Share by Type (2015-2020)
Table 46. Europe NT 3 Growth Factor Receptor Sales by Application (2015-2020) (K Pcs)
Table 47. Europe NT 3 Growth Factor Receptor Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific NT 3 Growth Factor Receptor Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific NT 3 Growth Factor Receptor Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific NT 3 Growth Factor Receptor Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific NT 3 Growth Factor Receptor Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific NT 3 Growth Factor Receptor Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific NT 3 Growth Factor Receptor Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific NT 3 Growth Factor Receptor Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific NT 3 Growth Factor Receptor Sales Market Share by Application (2015-2020)
Table 56. Latin America NT 3 Growth Factor Receptor Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America NT 3 Growth Factor Receptor Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa NT 3 Growth Factor Receptor Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America NT 3 Growth Factor Receptor Revenue Market Share by Country (2015-2020)
Table 60. Latin America NT 3 Growth Factor Receptor Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America NT 3 Growth Factor Receptor Sales Market Share by Type (2015-2020)
Table 62. Latin America NT 3 Growth Factor Receptor Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America NT 3 Growth Factor Receptor Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa NT 3 Growth Factor Receptor Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa NT 3 Growth Factor Receptor Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa NT 3 Growth Factor Receptor Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa NT 3 Growth Factor Receptor Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa NT 3 Growth Factor Receptor Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa NT 3 Growth Factor Receptor Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa NT 3 Growth Factor Receptor Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa NT 3 Growth Factor Receptor Sales Market Share by Application (2015-2020)
Table 72. Array BioPharma Inc Corporation Information
Table 73. Array BioPharma Inc Description and Major Businesses
Table 74. Array BioPharma Inc NT 3 Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Array BioPharma Inc Product
Table 76. Array BioPharma Inc Recent Development
Table 77. AstraZeneca Plc Corporation Information
Table 78. AstraZeneca Plc Description and Major Businesses
Table 79. AstraZeneca Plc NT 3 Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. AstraZeneca Plc Product
Table 81. AstraZeneca Plc Recent Development
Table 82. Daiichi Sankyo Company Ltd Corporation Information
Table 83. Daiichi Sankyo Company Ltd Description and Major Businesses
Table 84. Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Daiichi Sankyo Company Ltd Product
Table 86. Daiichi Sankyo Company Ltd Recent Development
Table 87. Handok Inc Corporation Information
Table 88. Handok Inc Description and Major Businesses
Table 89. Handok Inc NT 3 Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Handok Inc Product
Table 91. Handok Inc Recent Development
Table 92. Ignyta Inc Corporation Information
Table 93. Ignyta Inc Description and Major Businesses
Table 94. Ignyta Inc NT 3 Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Ignyta Inc Product
Table 96. Ignyta Inc Recent Development
Table 97. Loxo Oncology Inc Corporation Information
Table 98. Loxo Oncology Inc Description and Major Businesses
Table 99. Loxo Oncology Inc NT 3 Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Loxo Oncology Inc Product
Table 101. Loxo Oncology Inc Recent Development
Table 102. Netris Pharma SAS Corporation Information
Table 103. Netris Pharma SAS Description and Major Businesses
Table 104. Netris Pharma SAS NT 3 Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Netris Pharma SAS Product
Table 106. Netris Pharma SAS Recent Development
Table 107. Plexxikon Inc Corporation Information
Table 108. Plexxikon Inc Description and Major Businesses
Table 109. Plexxikon Inc NT 3 Growth Factor Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Plexxikon Inc Product
Table 111. Plexxikon Inc Recent Development
Table 112. Global NT 3 Growth Factor Receptor Sales Forecast by Regions (2021-2026) (K Pcs)
Table 113. Global NT 3 Growth Factor Receptor Sales Market Share Forecast by Regions (2021-2026)
Table 114. Global NT 3 Growth Factor Receptor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 115. Global NT 3 Growth Factor Receptor Revenue Market Share Forecast by Regions (2021-2026)
Table 116. North America: NT 3 Growth Factor Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. North America: NT 3 Growth Factor Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Europe: NT 3 Growth Factor Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Europe: NT 3 Growth Factor Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Asia Pacific: NT 3 Growth Factor Receptor Sales Forecast by Region (2021-2026) (K Pcs)
Table 121. Asia Pacific: NT 3 Growth Factor Receptor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 122. Latin America: NT 3 Growth Factor Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Latin America: NT 3 Growth Factor Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Middle East and Africa: NT 3 Growth Factor Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Middle East and Africa: NT 3 Growth Factor Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Main Points Interviewed from Key NT 3 Growth Factor Receptor Players
Table 130. NT 3 Growth Factor Receptor Customers List
Table 131. NT 3 Growth Factor Receptor Distributors List
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. NT 3 Growth Factor Receptor Product Picture
Figure 2. Global NT 3 Growth Factor Receptor Sales Market Share by Type in 2020 & 2026
Figure 3. AZD-7451 Product Picture
Figure 4. Larotrectinib Product Picture
Figure 5. DS-6051 Product Picture
Figure 6. LM-22B10 Product Picture
Figure 7. Others Product Picture
Figure 8. Global NT 3 Growth Factor Receptor Sales Market Share by Application in 2020 & 2026
Figure 9. Breast Cancer
Figure 10. Brain Cancer
Figure 11. Solid Tumor
Figure 12. Colon Cancer
Figure 13. Fibrosarcoma
Figure 14. Others
Figure 15. NT 3 Growth Factor Receptor Report Years Considered
Figure 16. Global NT 3 Growth Factor Receptor Market Size 2015-2026 (US$ Million)
Figure 17. Global NT 3 Growth Factor Receptor Sales 2015-2026 (K Pcs)
Figure 18. Global NT 3 Growth Factor Receptor Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global NT 3 Growth Factor Receptor Sales Market Share by Region (2015-2020)
Figure 20. Global NT 3 Growth Factor Receptor Sales Market Share by Region in 2019
Figure 21. Global NT 3 Growth Factor Receptor Revenue Market Share by Region (2015-2020)
Figure 22. Global NT 3 Growth Factor Receptor Revenue Market Share by Region in 2019
Figure 23. Global NT 3 Growth Factor Receptor Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by NT 3 Growth Factor Receptor Revenue in 2019
Figure 25. NT 3 Growth Factor Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global NT 3 Growth Factor Receptor Sales Market Share by Type (2015-2020)
Figure 27. Global NT 3 Growth Factor Receptor Sales Market Share by Type in 2019
Figure 28. Global NT 3 Growth Factor Receptor Revenue Market Share by Type (2015-2020)
Figure 29. Global NT 3 Growth Factor Receptor Revenue Market Share by Type in 2019
Figure 30. Global NT 3 Growth Factor Receptor Market Share by Price Range (2015-2020)
Figure 31. Global NT 3 Growth Factor Receptor Sales Market Share by Application (2015-2020)
Figure 32. Global NT 3 Growth Factor Receptor Sales Market Share by Application in 2019
Figure 33. Global NT 3 Growth Factor Receptor Revenue Market Share by Application (2015-2020)
Figure 34. Global NT 3 Growth Factor Receptor Revenue Market Share by Application in 2019
Figure 35. North America NT 3 Growth Factor Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America NT 3 Growth Factor Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America NT 3 Growth Factor Receptor Sales Market Share by Country in 2019
Figure 38. North America NT 3 Growth Factor Receptor Revenue Market Share by Country in 2019
Figure 39. U.S. NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America NT 3 Growth Factor Receptor Market Share by Type in 2019
Figure 44. North America NT 3 Growth Factor Receptor Market Share by Application in 2019
Figure 45. Europe NT 3 Growth Factor Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe NT 3 Growth Factor Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe NT 3 Growth Factor Receptor Sales Market Share by Country in 2019
Figure 48. Europe NT 3 Growth Factor Receptor Revenue Market Share by Country in 2019
Figure 49. Germany NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe NT 3 Growth Factor Receptor Market Share by Type in 2019
Figure 60. Europe NT 3 Growth Factor Receptor Market Share by Application in 2019
Figure 61. Asia Pacific NT 3 Growth Factor Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific NT 3 Growth Factor Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific NT 3 Growth Factor Receptor Sales Market Share by Region in 2019
Figure 64. Asia Pacific NT 3 Growth Factor Receptor Revenue Market Share by Region in 2019
Figure 65. China NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific NT 3 Growth Factor Receptor Market Share by Type in 2019
Figure 88. Asia Pacific NT 3 Growth Factor Receptor Market Share by Application in 2019
Figure 89. Latin America NT 3 Growth Factor Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America NT 3 Growth Factor Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America NT 3 Growth Factor Receptor Sales Market Share by Country in 2019
Figure 92. Latin America NT 3 Growth Factor Receptor Revenue Market Share by Country in 2019
Figure 93. Mexico NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America NT 3 Growth Factor Receptor Market Share by Type in 2019
Figure 100. Latin America NT 3 Growth Factor Receptor Market Share by Application in 2019
Figure 101. Middle East and Africa NT 3 Growth Factor Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa NT 3 Growth Factor Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa NT 3 Growth Factor Receptor Sales Market Share by Country in 2019
Figure 104. Middle East and Africa NT 3 Growth Factor Receptor Revenue Market Share by Country in 2019
Figure 105. Turkey NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E NT 3 Growth Factor Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E NT 3 Growth Factor Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa NT 3 Growth Factor Receptor Market Share by Type in 2019
Figure 112. Middle East and Africa NT 3 Growth Factor Receptor Market Share by Application in 2019
Figure 113. North America NT 3 Growth Factor Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America NT 3 Growth Factor Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe NT 3 Growth Factor Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe NT 3 Growth Factor Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific NT 3 Growth Factor Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific NT 3 Growth Factor Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America NT 3 Growth Factor Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America NT 3 Growth Factor Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa NT 3 Growth Factor Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa NT 3 Growth Factor Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed

---